| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 127374-96-3 | Acetamide,N-methyl-N-[4-(4-morpholinyl)-6-propyl-1,3,5-triazin-2-yl]- |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 148312-39-4 | Ethanol,2,2'-[[4-cyclopropyl-6-(cyclopropylamino)-1,3,5-triazin-2-yl]imino]bis- (9CI) |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 314-35-2 | 1H-Purine-2,6-dione,7-[2-(diethylamino)ethyl]-3,7-dihydro-1,3-dimethyl-; Theophylline,7-[2-(diethylamino)ethyl]- (6CI,7CI,8CI); 1,3-Dimethyl-7-(2-diethylaminoethyl)xanthine; 7-(2-Diethylaminoethyl)-1,3-dimethylxanthine; 7-(2-Diethylaminoethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione; 7-(Diethylaminoethyl)theophylline; 7-[2-(Diethylamino)ethyl]theophylline; Corafil; Dietamiphylline; Diethylaminoethyltheophylline; Etaminophylline; Etamiphyllin; Etamiphylline; Milliphylline; Millophyline; NSC 38348; Parephyllin; Queryl; R 3588; Soluphyline; Soluphylline |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 7499-86-7 | 1H-Purine-2,6-dione,3-butyl-8-(dimethylamino)-3,7-dihydro-1,7-dimethyl-; NSC 400057 |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 150131-79-6 | 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, (3R,4aS,6S,8aS)- (9CI); 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, [3R-(3a,4aa,6b,8aa)]-; LY 293559 |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 154652-83-2 | 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(2H-tetrazol-5-yl)ethyl]-, (3S,4aR,6R,8aR)-; 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, (3S,4aR,6R,8aR)- (9CI); 3-Isoquinolinecarboxylic acid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, [3S-(3a,4aa,6b,8aa)]-; LY 293558; NGX 424; Tezampanel |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 150010-68-7 | 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(2H-tetrazol-5-yl)ethyl]-, (3R,4aS,6S,8aS)-rel-; 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, (3R,4aS,6S,8aS)-rel- (9CI); 3-Isoquinolinecarboxylic acid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, (3a,4aa,6b,8aa)-(?à)-; 3-Isoquinolinecarboxylic acid,decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, (3a,4aa,6b,8aa)-; LY 215490 |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 150131-78-5 | 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(2H-tetrazol-5-yl)ethyl]-, (3S,4aR,6R,8aR)-; 3-Isoquinolinecarboxylicacid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, (3S,4aR,6R,8aR)- (9CI); 3-Isoquinolinecarboxylic acid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, [3S-(3a,4aa,6b,8aa)]-; LY 293558; NGX 424; Tezampanel |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 84332-20-7 | 5-Pyrimidinecarboxamide,2-amino-N-(1-ethyl-3-piperidinyl)-4-methoxy-; 2-Amino-N-(1-ethyl-3-piperidyl)-4-methoxy-5-pyrimidinecarboxamide |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 84332-18-3 | 5-Pyrimidinecarboxamide,2-amino-4-methoxy-N-[(1-methyl-2-piperidinyl)methyl]-; 2-Amino-4-methoxy-N-((1-methyl-2-piperidyl)methyl)-5-pyrimidinecarboxa mide |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 84332-23-0 | 5-Pyrimidinecarboxamide,2-amino-N-(1-ethyl-4-piperidinyl)-4-methoxy-; 2-Amino-N-(1-ethyl-4-piperidyl)-4-methoxy-5-pyrimidinecarboxamide |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 72412-36-3 | 5-Pyrimidinecarboxamide,2-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-4-methoxy-; 2-(2-Amino-4-methoxy-5-pyrimidinyl carboxamidomethyl)-1-ethylpyrrolidi ne |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |
| 84332-38-7 | 5-Pyrimidinecarboxamide,2-amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-4-methoxy-, (S)- (9CI) |  | C13H21N5O2 | 詳情 | 供應(yīng)商 | |